Intravenous Quinine Therapy of Hospitalized Children with Plasmodium falciparum Malaria in Kinshasa, Zaire

Alan E. Greenberg Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Alan E. Greenberg in
Current site
Google Scholar
PubMed Close
,
Phuc Nguyen-Dinh Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Phuc Nguyen-Dinh in
Current site
Google Scholar
PubMed Close
,
Farzin Davachi Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Farzin Davachi in
Current site
Google Scholar
PubMed Close
,
Bahwe Yemvula Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Bahwe Yemvula in
Current site
Google Scholar
PubMed Close
,
Nsuami Malanda Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Nsuami Malanda in
Current site
Google Scholar
PubMed Close
,
Matadi Nzeza Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Matadi Nzeza in
Current site
Google Scholar
PubMed Close
,
Sharyon B. Williams Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Sharyon B. Williams in
Current site
Google Scholar
PubMed Close
,
Joanne F. de Zwart Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Joanne F. de Zwart in
Current site
Google Scholar
PubMed Close
, and
Mayemba Nzeza Malaria Branch and Control Technology Branch, Division of Parasitic Diseases, Center for Infectious Diseases, Centers for Disease Control, Department of Pediatrics, Mama Yemo Hospital and Institut National de Recherche Biomedicale, Atlanta, Georgia

Search for other papers by Mayemba Nzeza in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1989.40.360
Volume/Issue:
Volume 40: Issue 4
Page(s):
360–364
Restricted access
Get Permissions

To examine the clinical and parasitologic efficacy of quinine, we studied 34 children (7 months–13 years old) with severe or moderately severe Plasmodium falciparum infections. Quinine 10 mg/kg every 8 hr for 3 days was administered, initially by intravenous infusion of quinine formate followed by oral quinine dihydrochloride when tolerated. Thirty-three of the 34 patients were clinically well and had negative malaria smears 7 days after the initiation of therapy; 1 child, who presented in coma, died 29 hr after enrollment. The mean fever clearance time was 44.1 hr, and the mean parasite clearance time was 59.6 hr. A mean peak quinine level of 9.7 ppm was attained after the second dose of quinine, and the minimum concentration was maintained at 5–7 ppm during the 2nd and 3rd hospital days. In vitro testing was conducted with parasites from 10 patients: 9 isolates were resistant to chloroquine, and inhibition of schizont development with quinine occurred at a concentration of 8–32 pmol/well.
Copyright:
Copyright © 1989 by The American Society of Tropical Medicine and Hygiene 1989
Published Online:
Apr 1989
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 268 109 8
Full Text Views 7 3 3
PDF Downloads 7 4 4
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save